• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

Recent Advances in the Application of 1-Bromo-3,5-bis(tert-butylthio)benzene (CAS: 795274-44-1) in Chemical and Pharmaceutical Research

1-Bromo-3,5-bis(tert-butylthio)benzene (CAS: 795274-44-1) is a specialized organic compound that has garnered significant attention in recent chemical and pharmaceutical research due to its unique structural properties and potential applications. This compound, characterized by its tert-butylthio groups and bromine substitution, serves as a versatile intermediate in the synthesis of complex molecules, particularly in the development of novel therapeutics and materials. Recent studies have explored its role in cross-coupling reactions, catalysis, and as a precursor for bioactive molecules, highlighting its importance in modern synthetic chemistry.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the use of 1-Bromo-3,5-bis(tert-butylthio)benzene as a key building block for the synthesis of sulfur-containing heterocycles, which are prominent scaffolds in drug discovery. The study demonstrated that the compound's tert-butylthio groups enhance steric hindrance, facilitating selective functionalization and improving yields in palladium-catalyzed reactions. This finding underscores its utility in the efficient construction of pharmacologically relevant structures, such as kinase inhibitors and antimicrobial agents.

Another notable application of 1-Bromo-3,5-bis(tert-butylthio)benzene was reported in Organic Letters (2024), where it was employed in the development of photoactive materials. The compound's ability to undergo controlled radical reactions under light irradiation enabled the synthesis of polymers with tunable electronic properties. These materials show promise for use in organic electronics and drug delivery systems, further expanding the compound's versatility beyond traditional synthetic chemistry.

From a pharmaceutical perspective, recent preclinical studies have explored the bioactivity of derivatives synthesized from 1-Bromo-3,5-bis(tert-butylthio)benzene. A 2024 European Journal of Medicinal Chemistry article highlighted its derivatives' potential as anti-inflammatory agents, with demonstrated efficacy in inhibiting NF-κB signaling pathways. The study emphasized the compound's role in optimizing drug-like properties, such as solubility and metabolic stability, through strategic modifications of its thioether groups.

Despite these advancements, challenges remain in scaling up the synthesis of 1-Bromo-3,5-bis(tert-butylthio)benzene and its derivatives for industrial applications. Recent process chemistry research (2023, Chemical Engineering Journal) has addressed this by developing greener synthetic routes using continuous flow technology, reducing reliance on hazardous reagents and improving overall sustainability. These efforts align with the growing demand for environmentally friendly methodologies in pharmaceutical manufacturing.

In conclusion, 1-Bromo-3,5-bis(tert-butylthio)benzene (CAS: 795274-44-1) continues to emerge as a valuable tool in chemical and pharmaceutical research. Its applications span from medicinal chemistry to materials science, driven by its unique reactivity and structural features. Future research directions may focus on expanding its utility in targeted drug delivery systems and exploring its potential in catalytic asymmetric synthesis, further solidifying its position as a multifaceted building block in modern chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)